Award
National Institute of Allergy and Infectious Diseases (NIAID) RFA-AI-24-076
Ultra-long-acting in-situ forming implant (ISFI) as a subcutaneous injection for prevention of HIV and unplanned pregnancy
Recipient
UNIV OF NORTH CAROLINA CHAPEL HILL
Award Amount
$1,106,984.00
Ceiling
$1,106,984.00
Awarded
April 17, 2026
Identifier
RFA-AI-24-076
Development of a biodegradable implant for HIV and pregnancy prevention, including safety and pharmacokinetics studies to support pre-IND application.
Description
The project focuses on developing a biodegradable, in-situ forming implant (ISFI) for HIV and pregnancy prevention. The project involves pharmacokinetics, safety evaluation in rodent and non-human primate models, and aims to support a pre-IND application.